We recently reported that reducing the accumulation of TRPV2 in the sarcolemma by overexpressing its NT domain protein prevented cardiac dysfunction [9,17] and DCM progression in animal models while also enhancing survival [9]. This evidence concerns the gene TRPV2 and familial dilated cardiomyopathy.